Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy
NfL and GFAP are promising biomarkers to identify women at risk of developing CIPN. Larger prospective studies are now needed.
Authors
- Zakaria Einbeigi (ORCID: https://orcid.org/0000-0003-2507-7197)
- Jamila Adra (ORCID: https://orcid.org/0000-0001-6361-661X)
- Henrik Zetterberg (ORCID: https://orcid.org/0000-0003-3930-4354)
- Daniel Giglio (ORCID: https://orcid.org/0000-0002-1349-9336)
- Per Karlsson (ORCID: https://orcid.org/0000-0003-4841-2672)
Institutions
- University of Wisconsin–Madison (US)
- Sahlgrenska University Hospital (SE)
- Södra Älvsborg Hospital (SE)
- UK Dementia Research Institute (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- University College London (GB)
- University of Gothenburg (SE)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2024-08-05
- DOI
- https://doi.org/10.2340/1651-226x.2024.39895
- Citations
- 9
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 2.54
Funders
- Alzheimer's Association
- Alzheimer's Drug Discovery Foundation
- Familjen Erling-Perssons Stiftelse
- Stiftelsen för Gamla Tjänarinnor
- EU Joint Programme – Neurodegenerative Disease Research
- National Institute for Health and Care Research
- University College London
- European Commission
- Cancerfonden
- Hjärnfonden
- Vetenskapsrådet
- UK Dementia Research Institute
- HORIZON EUROPE Framework Programme